Putative mechanisms for vascular damage by homocysteine

Journal of Inherited Metabolic Disease

Volumn 20, Issue 2, 1997, Pages 307-315

  Bellamy, M F ^a   Mcdowell, I F W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; NITRIC OXIDE; THROMBIN;

BLOOD VESSEL INJURY; CONFERENCE PAPER; EXTRACELLULAR MATRIX; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; LIPOPROTEIN METABOLISM; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; VASCULAR DISEASES;

EID: 0030917545     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005377310872     Document Type: Conference Paper

References (37)

1. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE (1995) Serum total homocysteine and coronary heart disease. Int J Epidemiol 24: 704-709.
2. 12/folate status. J Inher Metab Dis 19 (supplement 1): 23.
3. Blom HJ, Kleinveld HA, Boers GHJ, et al (1995) Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest 25: 149-154.
4. Blundell G, Jones BG, Rose FA, Tudball N (1996) Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 122: 163-172.
5. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 274: 1049-1057.
6. Busse R, Fleming I (1996) Endothelial dysfunction in atherosclerosis. J Vasc Res 33: 181-194.
7. Celermajer DS, Sorensen K, Ryalls M, et al (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not their heterozygous parents. J Am Coll Cardiol 22: 854-858.
8. Den Heijer M, Koster T, Blom HJ, et al (1996) Hyperhomocysteinaemia as a risk factor for deepvein thrombosis. N Engl J Med 334: 759-762.
9. Dudman NPB, Hicks C, Wang J, Wilcken DEL (1991) Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91: 77-83.
10. Dudman NPB, Wilcken DEL, Stocker R (1993) Circulating lipid hydroperoxide levels in human hyperhomocysteinaemia. Arterioscler Thromb 13: 512-516.
11. Flavahan NA (1992) Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 85: 1927-1938.
12. Gibson JB, Carson NAJ, Neill DW (1964) Pathological findings in homocystinuria. J Clin Pathol 17: 427-437.
13. Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731-741.
14. Harpel PC, Chang VT, Borth W (1992) Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 89: 10193-10197.
15. Jia L, Furchgott RF (1993) Inhibition by sulphydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther 267: 371-378.
16. Joannides R, Haefeli W, Linder L (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91: 1314-1319.
17. Kielty CM, Wilson DG, Stuart G, et al (1996) Fibrillin expression and deposition by vascular endothelial cells: implications for the Marfan syndrome. Circulation 94 (no. 8, supplement): I-350.
18. Lentz SR, Sobey CG, Piegors DJ, et al (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98: 24-29.
19. Loscalzo J (1996) The oxidant stress of hyperhomocysteinaemia [editorial]. J Clin Invest 98: 5-7.
20. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GHJ (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315: 159-162.
21. Mandel H, Brenner B, Berant M, et al (1996) Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 334: 763-768.
22. McCully KS, Wilson RB (1975) Homocysteine theory of arteriosclerosis. Atherosclerosis 22: 215-227.
23. Mudd SH, Skovby F, Levy HL, et al (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37: 1-31.
24. Mudd S, Levy HL, Skovby F (1995) Disorders of transsulfuration. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw Hill: 1279-1323.
25. Olszewski AJ, McCully KS (1993) Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radical Biol Med 14: 683-693.
26. Palmer R, Ashton D, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
27. Rees MM, Rodgers GM (1993) Homocysteinaemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 71: 337-359.
28. Ross R (1986) The pathogenesis of atherosclerosis - an update. N Engl J Med 314: 488-500.
29. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
30. Stamler JS, Loscalzo J (1992) Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine. J Cardiovasc Pharm 20 (supplement 12): S202-S204.
31. Stamler JS, Osborne JA, Jaraki O, et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91: 308-318.
32. Stampfer MJ, Malinow MR, Willet WC, et al (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 268: 877-881.
33. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77: 1370-1376.
34. Tsai JC, Wang H, Perrella MA, et al (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97: 146-153.
35. Upchurch GR, Welch GN, Freedman JE, Loscalzo J (1995) Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury. Circulation 92: I-228.
36. Wall RT, Harlan JM, Harker LA, Striker GE (1980) Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 18: 113-121.
37. Wilson DG, Bellamy MF, Goodfellow J, et al (1996) Abnormal flow-mediated brachial artery responses in patients with the Marfan syndrome. Circulation 94 (no. 8, supplement): I-105.